title: High prevalence of diabetes mellitus and hospital-related hyperglycaemia in French general wards.
abstract: OBJECTIVE
  The study evaluated the in-hospital prevalence of diabetes and hospital-related hyperglycaemia in a variety of French general wards.
  
  
  METHODS
  The multicentre cross-sectional study involving nine French hospitals measured venous fasting plasma glucose (FPG) on a single day in patients hospitalized in adult medical and surgical short-term wards. Diabetes status and length of stay were recorded.
  
  
  RESULTS
  Of the 2141 inpatients included in the study, 355 (16.5%) had known diabetes, 156 (7.3%) had screened diabetes (FPG ≥7 mmol/L with no diabetes history), 515 (24.1%) had impaired fasting glucose (IFG; FPG 5.5-6.9 mmol/L) and 1115 (52.1%) had normal glucose values (FPG < 5.5 mmol/L). Diabetes prevalence varied from 11% in hospitals in the west of France to 21% in hospitals in northern and eastern regions. The highest known diabetes prevalence was observed in units for cardiovascular surgery (33%), infectious diseases (27%) and kidney disorders (26%). In cancer units, one-fifth of patients had screened diabetes and one-sixth had known diabetes. Among the known diabetes patients, 127 (36%) were already being treated with insulin, while an additional 41 (12%) started insulin therapy during their hospital stay. Patients with known and screened diabetes were older (70.8 ± 12.2 and 71.1 ± 15.6 years, respectively) than the normal-glucose patients (65.6 ± 18.9 years; P<0.001). Average length of stay was no different between known diabetes and normal-glucose patients after adjusting for age (11.3 ± 7.7 vs 10.0 ± 7.4 days; NS).
  
  
  CONCLUSIONS
  Overall, metabolic glucose disorders (known or screened diabetes and IFG) were found in 48% of inpatients in various French hospital general wards.
authors.affiliation: CHNO des Quinze-Vingts, Department of Internal Medicine, 75012 Paris, France. Electronic address: s.feldman@quinze-vingts.fr.
authors.forename: S
authors.initials: S
authors.lastname: Feldman-Billard
authors.forename: M
authors.initials: M
authors.lastname: Joubert
authors.forename: R
authors.initials: R
authors.lastname: Morello
authors.forename: F
authors.initials: F
authors.lastname: Dorey
authors.forename: D
authors.initials: D
authors.lastname: Seret-Begue
authors.forename: F
authors.initials: F
authors.lastname: Getin-Bouyer
authors.forename: P
authors.initials: P
authors.lastname: Jan
authors.forename: A
authors.initials: A
authors.lastname: Colobert
authors.forename: E
authors.initials: E
authors.lastname: Verlet
authors.forename: M
authors.initials: M
authors.lastname: Roques
authors.forename: Y
authors.initials: Y
authors.lastname: Reznik
mesh_terms: D017677:Age Distribution; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000453:epidemiology; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000453:epidemiology*; D005215:Fasting; D005260:Female; D005602:France / Q000453:epidemiology; D006306:Health Surveys; D006760:Hospitalization; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000453:epidemiology*; D007674:Kidney Diseases / Q000453:epidemiology; D007902:Length of Stay / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged
chemical_list: D001786:Blood Glucose
keywords: Diabetes; Diabète; Durée de séjour; Hospitalisation; Hospitalization; Hyperglycaemia; Hyperglycémie; Length of stay; Prevalence; Prévalence